Jeffrey Mark Robbins, M.S.W.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Podiatry | 5 | 2018 | 22 | 1.390 |
Why?
|
Diabetic Foot | 9 | 2023 | 355 | 1.150 |
Why?
|
Ankle | 2 | 2023 | 327 | 0.780 |
Why?
|
Societies | 1 | 2018 | 104 | 0.630 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3677 | 0.370 |
Why?
|
Toes | 2 | 2021 | 206 | 0.340 |
Why?
|
Wound Healing | 2 | 2015 | 2776 | 0.250 |
Why?
|
Lower Extremity | 2 | 2023 | 1158 | 0.240 |
Why?
|
Wound Infection | 1 | 2006 | 242 | 0.240 |
Why?
|
Myocardium | 5 | 2007 | 4775 | 0.230 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3608 | 0.230 |
Why?
|
Onychomycosis | 1 | 2003 | 47 | 0.220 |
Why?
|
Data Display | 3 | 2006 | 182 | 0.180 |
Why?
|
Microfilament Proteins | 1 | 2005 | 1152 | 0.180 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.180 |
Why?
|
Patient Education as Topic | 1 | 2008 | 2278 | 0.160 |
Why?
|
Myocardial Contraction | 5 | 2007 | 1579 | 0.160 |
Why?
|
Antifungal Agents | 1 | 2003 | 729 | 0.160 |
Why?
|
History, 21st Century | 3 | 2020 | 1532 | 0.150 |
Why?
|
Physicians | 1 | 2015 | 4569 | 0.150 |
Why?
|
History, 20th Century | 4 | 2020 | 2736 | 0.150 |
Why?
|
Myocytes, Cardiac | 6 | 2012 | 1631 | 0.140 |
Why?
|
Informed Consent | 1 | 2023 | 995 | 0.140 |
Why?
|
Carrier Proteins | 2 | 2006 | 5021 | 0.140 |
Why?
|
Diabetes Complications | 1 | 2003 | 1360 | 0.130 |
Why?
|
International Classification of Diseases | 1 | 2021 | 866 | 0.130 |
Why?
|
Operating Room Information Systems | 2 | 2005 | 15 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2023 | 941 | 0.130 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 2 | 2007 | 202 | 0.120 |
Why?
|
Receptor, Angiotensin, Type 2 | 2 | 2004 | 67 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3921 | 0.120 |
Why?
|
Patient Care Team | 4 | 2010 | 2528 | 0.110 |
Why?
|
Heart | 2 | 2005 | 4460 | 0.110 |
Why?
|
Hospitals, Veterans | 2 | 2006 | 404 | 0.110 |
Why?
|
Ischemia | 1 | 2021 | 1907 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1164 | 0.100 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5752 | 0.100 |
Why?
|
Mice, Transgenic | 8 | 2008 | 9731 | 0.100 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2012 | 199 | 0.090 |
Why?
|
Reoperation | 1 | 2020 | 4200 | 0.090 |
Why?
|
Systems Integration | 3 | 2006 | 440 | 0.080 |
Why?
|
Glycogen Storage Disease Type IIb | 1 | 2007 | 18 | 0.080 |
Why?
|
alpha-Crystallin B Chain | 1 | 2007 | 23 | 0.080 |
Why?
|
Limb Salvage | 1 | 2010 | 433 | 0.080 |
Why?
|
Temperature | 2 | 2024 | 2202 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3020 | 0.070 |
Why?
|
Calcineurin | 1 | 2008 | 226 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 2874 | 0.070 |
Why?
|
Heart Conduction System | 1 | 2012 | 1047 | 0.070 |
Why?
|
Neuropeptides | 1 | 2012 | 942 | 0.070 |
Why?
|
Hospital Information Systems | 2 | 2005 | 395 | 0.070 |
Why?
|
Public Health | 1 | 2018 | 2603 | 0.070 |
Why?
|
Heart Injuries | 1 | 2007 | 210 | 0.070 |
Why?
|
Curriculum | 1 | 2018 | 3603 | 0.060 |
Why?
|
Reflex | 1 | 2007 | 365 | 0.060 |
Why?
|
Bradycardia | 1 | 2007 | 307 | 0.060 |
Why?
|
Myosins | 1 | 2006 | 409 | 0.060 |
Why?
|
Energy Metabolism | 4 | 2012 | 2899 | 0.060 |
Why?
|
Myosin Heavy Chains | 1 | 2006 | 414 | 0.060 |
Why?
|
Phosphorylation | 2 | 2006 | 8436 | 0.060 |
Why?
|
Interdisciplinary Communication | 2 | 2010 | 950 | 0.060 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 686 | 0.060 |
Why?
|
Endocrinology | 1 | 2010 | 442 | 0.060 |
Why?
|
Sympathetic Nervous System | 1 | 2007 | 513 | 0.060 |
Why?
|
Autophagy | 1 | 2012 | 1296 | 0.060 |
Why?
|
Medical Informatics Applications | 1 | 2006 | 186 | 0.060 |
Why?
|
Sarcomeres | 1 | 2006 | 374 | 0.060 |
Why?
|
Humans | 22 | 2024 | 743811 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2007 | 820 | 0.060 |
Why?
|
Internship and Residency | 1 | 2023 | 5787 | 0.060 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2006 | 476 | 0.060 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2006 | 1723 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2006 | 549 | 0.050 |
Why?
|
Cardiomegaly | 1 | 2005 | 621 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2012 | 2267 | 0.050 |
Why?
|
Amino Acid Substitution | 1 | 2006 | 1793 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2007 | 950 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2010 | 1476 | 0.050 |
Why?
|
Interviews as Topic | 3 | 2021 | 2538 | 0.050 |
Why?
|
Orthopedics | 1 | 2010 | 904 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2012 | 2150 | 0.050 |
Why?
|
Mice | 11 | 2012 | 81154 | 0.050 |
Why?
|
United States | 6 | 2023 | 69859 | 0.050 |
Why?
|
Clinical Protocols | 1 | 2006 | 1459 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2620 | 0.050 |
Why?
|
Directive Counseling | 1 | 2021 | 166 | 0.040 |
Why?
|
Operating Rooms | 1 | 2006 | 817 | 0.040 |
Why?
|
Heart Failure | 4 | 2008 | 10896 | 0.040 |
Why?
|
Fibrosis | 1 | 2005 | 2030 | 0.040 |
Why?
|
Cell Lineage | 1 | 2007 | 2506 | 0.040 |
Why?
|
Binding Sites | 1 | 2006 | 6111 | 0.040 |
Why?
|
Animals | 13 | 2012 | 168660 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2003 | 851 | 0.040 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6620 | 0.040 |
Why?
|
Adenosine Triphosphate | 3 | 2008 | 2029 | 0.040 |
Why?
|
Health Policy | 2 | 2010 | 2662 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2012 | 14563 | 0.030 |
Why?
|
Hydrolysis | 2 | 2007 | 683 | 0.030 |
Why?
|
Extremities | 1 | 2021 | 867 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13809 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2006 | 1911 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3566 | 0.030 |
Why?
|
Europe | 2 | 2010 | 3336 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2023 | 1642 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 18107 | 0.030 |
Why?
|
Heart Rate | 3 | 2012 | 4091 | 0.030 |
Why?
|
Echocardiography | 1 | 2005 | 5096 | 0.030 |
Why?
|
Promoter Regions, Genetic | 3 | 2012 | 5867 | 0.030 |
Why?
|
Microscopy, Electron | 2 | 2008 | 2646 | 0.030 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2012 | 57 | 0.030 |
Why?
|
Animals, Genetically Modified | 2 | 2007 | 1552 | 0.020 |
Why?
|
Muscle Cells | 1 | 2012 | 197 | 0.020 |
Why?
|
Military Personnel | 1 | 2020 | 1133 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1956 | 0.020 |
Why?
|
Oxygen Consumption | 2 | 2008 | 1869 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 72252 | 0.020 |
Why?
|
Rabbits | 2 | 2007 | 4894 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12744 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 505 | 0.020 |
Why?
|
Phenotype | 1 | 2006 | 16361 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3058 | 0.020 |
Why?
|
Aging | 1 | 2007 | 8655 | 0.020 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2007 | 69 | 0.020 |
Why?
|
Veratrine | 1 | 2007 | 6 | 0.020 |
Why?
|
Tetracycline | 1 | 2007 | 214 | 0.020 |
Why?
|
Dobutamine | 1 | 2007 | 123 | 0.020 |
Why?
|
Glycogen | 1 | 2007 | 259 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3839 | 0.020 |
Why?
|
Male | 6 | 2021 | 349776 | 0.020 |
Why?
|
Phosphocreatine | 1 | 2008 | 270 | 0.020 |
Why?
|
North America | 1 | 2010 | 1249 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2008 | 3758 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2008 | 425 | 0.020 |
Why?
|
Atropine | 1 | 2007 | 244 | 0.020 |
Why?
|
Electrocardiography | 2 | 2012 | 6441 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 1157 | 0.020 |
Why?
|
Veterans | 1 | 2020 | 2519 | 0.020 |
Why?
|
Heart Ventricles | 2 | 2012 | 3817 | 0.020 |
Why?
|
Muscarinic Antagonists | 1 | 2007 | 137 | 0.020 |
Why?
|
Phenylephrine | 1 | 2007 | 301 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2006 | 89 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2012 | 19232 | 0.020 |
Why?
|
Baroreflex | 1 | 2007 | 146 | 0.020 |
Why?
|
Female | 6 | 2021 | 380020 | 0.020 |
Why?
|
Adenosine Monophosphate | 1 | 2008 | 275 | 0.020 |
Why?
|
Creatine | 1 | 2008 | 421 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 13869 | 0.020 |
Why?
|
Information Management | 1 | 2006 | 101 | 0.020 |
Why?
|
Rats | 2 | 2012 | 24250 | 0.020 |
Why?
|
Smoke | 1 | 2007 | 227 | 0.020 |
Why?
|
Propranolol | 1 | 2007 | 502 | 0.020 |
Why?
|
Thermodynamics | 1 | 2006 | 595 | 0.020 |
Why?
|
Ammonium Chloride | 1 | 2004 | 73 | 0.020 |
Why?
|
Calcium-Transporting ATPases | 1 | 2004 | 123 | 0.020 |
Why?
|
Electrophysiology | 1 | 2007 | 1297 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2007 | 506 | 0.020 |
Why?
|
Database Management Systems | 1 | 2006 | 270 | 0.020 |
Why?
|
Isoproterenol | 1 | 2004 | 399 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2007 | 610 | 0.020 |
Why?
|
Vagus Nerve | 1 | 2007 | 439 | 0.010 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2004 | 126 | 0.010 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2004 | 152 | 0.010 |
Why?
|
Dietary Fats | 1 | 2012 | 2016 | 0.010 |
Why?
|
Databases as Topic | 1 | 2006 | 474 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1542 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2004 | 683 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 77410 | 0.010 |
Why?
|
Myosin Light Chains | 1 | 2003 | 121 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2010 | 1503 | 0.010 |
Why?
|
Ventricular Function, Left | 2 | 2007 | 3660 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2110 | 0.010 |
Why?
|
Autonomic Nervous System | 1 | 2007 | 671 | 0.010 |
Why?
|
Isoenzymes | 1 | 2006 | 1728 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5881 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2007 | 1760 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20948 | 0.010 |
Why?
|
Ventricular Function | 1 | 2003 | 415 | 0.010 |
Why?
|
Cardiotonic Agents | 1 | 2004 | 535 | 0.010 |
Why?
|
Angiotensin II | 1 | 2004 | 880 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2007 | 1240 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2007 | 1027 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2006 | 2725 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 824 | 0.010 |
Why?
|
Models, Animal | 1 | 2006 | 2172 | 0.010 |
Why?
|
Risk Adjustment | 1 | 2003 | 594 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23327 | 0.010 |
Why?
|
Glucose | 1 | 2012 | 4398 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5179 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2004 | 2556 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1081 | 0.010 |
Why?
|
United States Department of Veterans Affairs | 1 | 2004 | 875 | 0.010 |
Why?
|
Medical Order Entry Systems | 1 | 2005 | 545 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2006 | 957 | 0.010 |
Why?
|
Random Allocation | 1 | 2003 | 2429 | 0.010 |
Why?
|
Education, Medical | 1 | 2010 | 1722 | 0.010 |
Why?
|
Societies, Medical | 1 | 2010 | 3740 | 0.010 |
Why?
|
Aged | 2 | 2021 | 163178 | 0.010 |
Why?
|
Time Factors | 2 | 2012 | 40038 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 213241 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2006 | 3622 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2012 | 9648 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6380 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 21824 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12066 | 0.010 |
Why?
|
Disease Management | 1 | 2004 | 2459 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12209 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10477 | 0.010 |
Why?
|
Blood Pressure | 1 | 2007 | 8551 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9440 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18355 | 0.010 |
Why?
|
Gene Expression | 1 | 2003 | 7793 | 0.010 |
Why?
|
Chronic Disease | 1 | 2004 | 9139 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23398 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2010 | 63042 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 25032 | 0.000 |
Why?
|